Grants
Showing of 28 results
Case Comprehensive Cancer Center receives $25.5M grant renewal to continue work in cancer treatment, prevention, and therapeutic innovation
The renewal marks 38 years of continuous NCI funding, dating back to the organization’s founding in 1987.
St. Baldrick’s Grant Awarded to UH Rainbow Physician Researcher for Pediatric Neuroblastoma Study
The grant will support Dr. John Letterio’s project titled, “Development of a Novel NF-κB Targeting Agent for Pediatric Neuroblastoma” focused on improving treatment outcomes for children with high-risk neuroblastoma.
C-Path’s Translational Therapeutics Accelerator Announces $200,000 Grant for Drug Development Project in Inflammatory Bowel Disease
University Hospitals Cleveland Medical Center physician awarded funding to advance novel therapy for IBD.
Harrington Discovery Institute Announces 2025 Scholar-Innovator Award Recipients
Drug development grant will advance 10 physician-scientists’ discoveries toward the clinic.
UH Seidman Cancer Center Researcher Awarded New Gastrointestinal Cancer Grant from NCCN in Collaboration with Taiho Oncology, Inc.
Dr. Madison Conces was awarded for a Phase II Clinical Trial of Trifluridine/Tipiracil plus Oxaliplatin in Patients with Advanced or Metastatic Biliary Tract Cancer Following First-Line Therapy.
University Hospitals and Case Western Reserve University Collaborative Science Pilot Awards Infuse $250,000 to Accelerate Five Promising Research Projects
In the spirit of encouraging and rapidly advancing team science between clinical and basic science faculty, UH and CWRU have jointly funded five research teams engaged in new and promising scientific studies.
University Hospitals Urology Institute Awarded $9.2 Million by the Patient Centered Outcomes Research Institute
Study will compare bulking versus sling for treating urinary incontinence at the time of vaginal prolapse repair.
Researchers awarded $2.8M federal grant to study potential treatment of Sudden Infant Death Syndrome
Using a model they developed that mimics conditions associated with most SIDS cases, researchers hope the federal support and new approach may provide a fresh perspective.